| SYMPATHOMIMETICS |
MIX-ACTING DRUGS |
Unfinished |
2021-11-21 |
jamesxiong |
5 |
0 |
edit |
|
| ALZHEMIER |
DRUGS FOR ALZHEIMER'S |
Unfinished |
2021-12-12 |
jamesxiong |
8 |
0 |
edit |
|
| MEDICINAL CHEMISTRY |
RAULINS 1.7 |
Unfinished |
2021-12-12 |
jamesxiong |
19 |
0 |
edit |
|
| SUPPLEMENTS |
1.7 NATURAL PRODUCTS/DRUGS |
Unfinished |
2021-12-12 |
jamesxiong |
20 |
0 |
edit |
|
| Top 200 |
Generic/Brand + indications +category |
Unfinished |
2022-12-29 |
jamesxiong |
100 |
0 |
edit |
|
| TOP 200 |
BRAND/GENERIC |
Unfinished |
2022-12-20 |
jamesxiong |
99 |
0 |
edit |
|
| TOP 200 |
Drug (generic) and category |
Unfinished |
2022-01-13 |
jamesxiong |
95 |
0 |
edit |
|
| ADE |
Adverse Drug Events and Safety |
Unfinished |
2022-01-13 |
jamesxiong |
17 |
0 |
edit |
|
| DAY 4C |
Medical Informatics |
Unfinished |
2022-01-13 |
jamesxiong |
5 |
0 |
edit |
|
| DAY 4B |
DRUG INFORMATION AND ORGANIZATION |
Unfinished |
2022-01-13 |
jamesxiong |
10 |
0 |
edit |
|
| DAY 4A |
DRUG REGULATORY IN REGULATORY AFFAIRS |
Unfinished |
2022-01-13 |
jamesxiong |
5 |
0 |
edit |
|
| PHAR 414 |
DAY 1: CLINICAL TRAIL DESIGN |
Unfinished |
2022-01-13 |
jamesxiong |
7 |
0 |
edit |
|
| 413: DAY 1 |
HEMATOLOGY AND IMMUNOLOGY |
Unfinished |
2022-01-11 |
jamesxiong |
35 |
0 |
edit |
|
| DAY2 |
HEMATOLOGY AND IMMUNOLOGY |
Unfinished |
2022-01-12 |
jamesxiong |
1 |
0 |
edit |
|
| BLOOD |
hemostasis Dr. Riccio |
Unfinished |
2022-09-25 |
jamesxiong |
46 |
0 |
edit |
|
| IMMUNOLOGY |
1.9 DR. MANDEL |
Unfinished |
2022-01-27 |
jamesxiong |
93 |
0 |
edit |
|
| INNATE IMMUNITY |
1.9 |
Unfinished |
2022-01-27 |
jamesxiong |
18 |
0 |
edit |
|
| T-LYMPHOCYTE |
DAY3 1.9 |
Unfinished |
2022-01-26 |
jamesxiong |
20 |
0 |
edit |
|
| DAY4 |
TCR AND BCR DEVELOPMENT |
Unfinished |
2022-01-28 |
jamesxiong |
35 |
0 |
edit |
|
| IMMUNE TOLERANCE |
DAY 4 |
Unfinished |
2022-01-29 |
jamesxiong |
20 |
0 |
edit |
|
| B-LYMPHOCYTE |
DAY 4 |
Unfinished |
2022-01-28 |
jamesxiong |
22 |
0 |
edit |
|
| immunization |
Day 5 |
Unfinished |
2022-01-28 |
jamesxiong |
2 |
0 |
edit |
|
| Complement Sys. |
DAY5 |
Unfinished |
2022-01-30 |
jamesxiong |
31 |
0 |
edit |
|
| Type 1 |
Hypersensitivity |
Unfinished |
2022-02-02 |
jamesxiong |
22 |
0 |
edit |
|
| Type 2/3 |
Hypersensitivity |
Unfinished |
2022-02-03 |
jamesxiong |
2 |
0 |
edit |
|
| Immunodeficiencies |
1.9 |
Unfinished |
2022-02-03 |
jamesxiong |
26 |
0 |
edit |
|
| Tissue Transplant |
1.9 |
Unfinished |
2022-02-03 |
jamesxiong |
34 |
0 |
edit |
|
| CARDIOVASCULAR |
TALBOT |
Unfinished |
2022-02-03 |
jamesxiong |
13 |
0 |
edit |
|
| Mendel Drugs |
Mendel Drugs |
Unfinished |
2022-02-06 |
jamesxiong |
23 |
0 |
edit |
|
| Talbot |
1.9 |
Unfinished |
2022-02-06 |
jamesxiong |
41 |
0 |
edit |
|
| Heart Failure |
1.10 |
Unfinished |
2022-02-08 |
jamesxiong |
53 |
0 |
edit |
|
| Angina |
1.10 |
Unfinished |
2022-08-05 |
jamesxiong |
15 |
0 |
edit |
|
| Arrhythmias |
1.10 |
Unfinished |
2022-02-09 |
jamesxiong |
10 |
0 |
edit |
|
| HYPERTENSION |
1.10 |
Unfinished |
2022-08-05 |
jamesxiong |
18 |
0 |
edit |
|
| Diuretics |
1.10 |
Unfinished |
2022-02-13 |
jamesxiong |
24 |
0 |
edit |
|
| Pulmonary Pharm. |
1.10 |
Unfinished |
2022-07-31 |
jamesxiong |
40 |
0 |
edit |
|
| Nausea/Vomitting |
Drugs |
Unfinished |
2022-02-15 |
jamesxiong |
18 |
0 |
edit |
|
| gastric drugs |
1.10 |
Unfinished |
2022-02-18 |
jamesxiong |
26 |
0 |
edit |
|
| 1.10 |
HYPERTENSTIVE DRUGS |
Unfinished |
2022-02-15 |
jamesxiong |
34 |
0 |
edit |
|
| Diuretics Drugs |
1.10 |
Unfinished |
2022-02-16 |
jamesxiong |
42 |
0 |
edit |
|
| GI DRUGS |
1.10 |
Unfinished |
2022-02-16 |
jamesxiong |
8 |
0 |
edit |
|
| MUSCLE |
1.10 |
Unfinished |
2022-02-16 |
jamesxiong |
19 |
0 |
edit |
|
| Erectile Dysfunction |
1.10 |
Unfinished |
2022-02-16 |
jamesxiong |
15 |
0 |
edit |
|
| bladder drugs |
1.10 |
Unfinished |
2022-02-21 |
jamesxiong |
12 |
0 |
edit |
|
| Hypothala/Pituitaary |
1.11 Drugs |
Unfinished |
2022-02-28 |
jamesxiong |
56 |
0 |
edit |
|
| Corticosteroids |
1.11 |
Unfinished |
2022-02-24 |
jamesxiong |
12 |
0 |
edit |
|
| Thyroid |
1.11 |
Unfinished |
2022-03-03 |
jamesxiong |
16 |
0 |
edit |
|
| Drug Stability |
1.11 |
Unfinished |
2022-03-01 |
jamesxiong |
14 |
0 |
edit |
|
| Drugs |
1.11 |
Unfinished |
2022-03-02 |
jamesxiong |
20 |
0 |
edit |
|
| Drugs Calcium |
1.11 |
Unfinished |
2022-03-03 |
jamesxiong |
10 |
0 |
edit |
|
| Dr. Lee |
1.11 |
Unfinished |
2022-03-03 |
jamesxiong |
37 |
0 |
edit |
|
| DAY1: PEDIATRIC |
1.14 |
Unfinished |
2022-04-12 |
jamesxiong |
2 |
0 |
edit |
|
| Oral Solids |
1.12 |
Unfinished |
2022-03-23 |
jamesxiong |
51 |
0 |
edit |
|
| Excipients |
1.12 |
Unfinished |
2022-03-22 |
jamesxiong |
15 |
0 |
edit |
|
| Day 2 Stuff |
1.12 |
Unfinished |
2022-03-23 |
jamesxiong |
40 |
0 |
edit |
|
| OPTIC/OTIC |
1.12 DAY 3 |
Unfinished |
2022-03-24 |
jamesxiong |
68 |
0 |
edit |
|
| TEAM ACT. 2 |
1.12 DAY 2 |
Unfinished |
2022-03-23 |
jamesxiong |
7 |
0 |
edit |
|
| Parental Products |
1.12 |
Unfinished |
2022-03-24 |
jamesxiong |
41 |
0 |
edit |
|
| Sterile LAB |
1.12 |
Unfinished |
2022-03-24 |
jamesxiong |
9 |
0 |
edit |
|
| DAY 1: PART 1 |
1.13 |
Unfinished |
2022-03-29 |
jamesxiong |
37 |
0 |
edit |
|
| DAY1: PART 2 |
1.13 |
Unfinished |
2022-03-29 |
jamesxiong |
22 |
0 |
edit |
|
| DAY1: PART 3 |
1.13 |
Unfinished |
2022-03-29 |
jamesxiong |
10 |
0 |
edit |
|
| BIOAVAILABILITY |
1.13 |
Unfinished |
2022-04-04 |
jamesxiong |
23 |
0 |
edit |
|
| RENAL/HEPATIC |
1.13 |
Unfinished |
2022-04-06 |
jamesxiong |
18 |
0 |
edit |
|
| DAY1: GERIATRICS |
1.14 |
Unfinished |
2022-04-12 |
jamesxiong |
2 |
0 |
edit |
|
| DAY2: PHARMCO |
1.14 |
Unfinished |
2022-04-13 |
jamesxiong |
49 |
0 |
edit |
|
| DAY3 |
1.14 |
Unfinished |
2022-04-15 |
jamesxiong |
34 |
0 |
edit |
|
| DAY4 |
1.14 |
Unfinished |
2022-04-15 |
jamesxiong |
5 |
0 |
edit |
|
| Bacteria Groups |
1.14 bacteria groups |
Unfinished |
2022-04-15 |
jamesxiong |
10 |
0 |
edit |
|
| Cephasporins |
1.14 |
Unfinished |
2022-04-16 |
jamesxiong |
22 |
0 |
edit |
|
| ANTI-METABOLSIM |
1.14 |
Unfinished |
2022-04-18 |
jamesxiong |
16 |
0 |
edit |
|
| ANTI-FUNGAL |
1.14 |
Unfinished |
2022-04-25 |
jamesxiong |
26 |
0 |
edit |
|
| kale toxicology |
1.14 |
Unfinished |
2022-04-21 |
jamesxiong |
26 |
0 |
edit |
|
| Protozoan |
1.14 |
Unfinished |
2022-04-25 |
jamesxiong |
26 |
0 |
edit |
|
| ANTI-VIRAL |
1.15 LEE |
Unfinished |
2022-05-01 |
jamesxiong |
32 |
0 |
edit |
|
| HIV MEDS |
1.15 LEE |
Unfinished |
2022-07-05 |
jamesxiong |
53 |
1 |
edit |
|
| de YOUNG |
1.15 |
Unfinished |
2022-05-02 |
jamesxiong |
12 |
0 |
edit |
|
| TOP200 B |
TOP200 B |
Unfinished |
2022-05-16 |
jamesxiong |
100 |
0 |
edit |
|
| GI DRUGS |
1.10 Dr. SO |
Unfinished |
2022-08-04 |
jamesxiong |
73 |
0 |
edit |
|
| 2.1 |
Obesity |
Unfinished |
2022-08-31 |
jamesxiong |
40 |
0 |
edit |
|
| 2.1 |
Clinical Nutrition |
Unfinished |
2022-09-01 |
jamesxiong |
30 |
0 |
edit |
|
| 2.1 |
ENTERAL/PARENTAL NUTRITION |
Unfinished |
2022-08-29 |
jamesxiong |
41 |
0 |
edit |
|
| 2.1 |
DRUG LITERATURE |
Unfinished |
2022-08-31 |
jamesxiong |
35 |
0 |
edit |
|
| Infant Formulation |
2.1 |
Unfinished |
2022-09-02 |
jamesxiong |
7 |
0 |
edit |
|
| SIADH DRUGS |
2.2 DRUGS |
Unfinished |
2022-09-13 |
jamesxiong |
16 |
0 |
edit |
|
| Phos-binders |
Hyperphosphatemia |
Unfinished |
2022-09-15 |
jamesxiong |
14 |
0 |
edit |
|
| Stack #3611520 |
Stack #3611520 |
Unfinished |
2022-09-16 |
jamesxiong |
10 |
0 |
edit |
|
| VTE PROPHYLAXIS |
DRUGS |
Unfinished |
2022-09-26 |
jamesxiong |
12 |
0 |
edit |
|
| statins |
dr. williams |
Unfinished |
2022-09-26 |
jamesxiong |
14 |
0 |
edit |
|
| hypertension |
dr. williams (cardio) |
Unfinished |
2022-09-26 |
jamesxiong |
31 |
0 |
edit |
|
| lipidemia |
williams |
Unfinished |
2022-09-29 |
jamesxiong |
7 |
0 |
edit |
|
| Heart Failure |
2.4 |
Unfinished |
2022-10-15 |
jamesxiong |
12 |
0 |
edit |
|
| DIABETES |
2.5 |
Unfinished |
2022-10-26 |
jamesxiong |
23 |
0 |
edit |
|
| Drugs |
2.5 |
Unfinished |
2022-10-27 |
jamesxiong |
27 |
0 |
edit |
|
| Insulin |
2.5 |
Unfinished |
2022-10-30 |
jamesxiong |
12 |
0 |
edit |
|
| Hormones |
2.5 |
Unfinished |
2022-11-02 |
jamesxiong |
1 |
0 |
edit |
|
| N/V |
2.6 |
Unfinished |
2022-11-17 |
jamesxiong |
36 |
0 |
edit |
|
| pancreitis |
2.6 |
Unfinished |
2022-11-17 |
jamesxiong |
37 |
0 |
edit |
|
| Constipation/Diarrhe |
2.6 |
Unfinished |
2022-11-18 |
jamesxiong |
38 |
0 |
edit |
|
| LEE |
2.6 |
Unfinished |
2022-11-21 |
jamesxiong |
35 |
0 |
edit |
|
| Peptic Ulcer |
2.6 |
Unfinished |
2022-11-19 |
jamesxiong |
6 |
0 |
edit |
|
| Dr. Dey |
2.6 |
Unfinished |
2022-11-21 |
jamesxiong |
44 |
0 |
edit |
|
| GOUT |
2.7 |
Unfinished |
2022-11-29 |
jamesxiong |
29 |
0 |
edit |
|
| LEE-transplate |
2.7 |
Unfinished |
2022-11-30 |
jamesxiong |
5 |
0 |
edit |
|
| TOP100A |
Dosage |
Unfinished |
2022-12-30 |
jamesxiong |
99 |
0 |
edit |
|
| TOP100A |
Strength |
Unfinished |
2023-01-02 |
jamesxiong |
92 |
0 |
edit |
|
| KEY PATHOGENS |
2.8 |
Unfinished |
2023-01-08 |
jamesxiong |
54 |
0 |
edit |
|
| Drugs for Bacteria |
Antibotics |
Unfinished |
2023-01-11 |
jamesxiong |
106 |
0 |
edit |
|
| Drugs Resistant |
Antibiotic Resistance |
Unfinished |
2023-01-12 |
jamesxiong |
27 |
0 |
edit |
|
| SSSI |
2.9 Peterson |
Unfinished |
2023-01-25 |
jamesxiong |
22 |
0 |
edit |
|
| HAP/CAP |
2.9 peterson |
Unfinished |
2023-01-26 |
jamesxiong |
8 |
0 |
edit |
|
| CAP |
2.9 DECERBO |
Unfinished |
2023-01-29 |
jamesxiong |
16 |
0 |
edit |
|
| Endocarditis |
2.9 Resident |
Unfinished |
2023-01-28 |
jamesxiong |
18 |
0 |
edit |
|
| Meningitis |
2.9 |
Unfinished |
2023-01-30 |
jamesxiong |
20 |
0 |
edit |
|
| HIV -part 1 |
2.9 DECERBO |
Unfinished |
2023-02-02 |
jamesxiong |
15 |
0 |
edit |
|
| ANTI-VIRAL |
2.10 |
Unfinished |
2023-02-13 |
jamesxiong |
61 |
0 |
edit |
|
| HIV prevention |
2.10 |
Unfinished |
2023-02-09 |
jamesxiong |
17 |
0 |
edit |
|
| HIV |
2.10 |
Unfinished |
2023-02-14 |
jamesxiong |
33 |
0 |
edit |
|
| Opportun. Infection |
2.10 |
Unfinished |
2023-02-15 |
jamesxiong |
19 |
0 |
edit |
|
| ANTI-FUNGAL |
2.10 |
Unfinished |
2023-02-15 |
jamesxiong |
82 |
0 |
edit |
|
| BUGS/DRUGS |
2.10 ANTI-FUNGAL |
Unfinished |
2023-02-13 |
jamesxiong |
19 |
0 |
edit |
|
| Abdominal infection |
1.10 decerbo |
Unfinished |
2023-02-13 |
jamesxiong |
2 |
0 |
edit |
|
| UTI |
2.10 |
Unfinished |
2023-02-14 |
jamesxiong |
3 |
0 |
edit |
|
| Day 1 |
2.11 madison |
Unfinished |
2023-02-22 |
jamesxiong |
3 |
0 |
edit |
|
| BPH/ED/Testosterone |
2.11 LEE |
Unfinished |
2023-02-28 |
jamesxiong |
48 |
0 |
edit |
|
| MENOPAUSE |
2.11 Riccio |
Unfinished |
2023-02-26 |
jamesxiong |
1 |
0 |
edit |
|
| Pregnancy Therap. |
2.11 Madison |
Unfinished |
2023-03-03 |
jamesxiong |
22 |
0 |
edit |
|
| Toxicology Pregnancy |
2.11 Madison |
Unfinished |
2023-03-03 |
jamesxiong |
23 |
0 |
edit |
|
| Oncology Intro |
2.12 Dr. Gundrum |
Unfinished |
2023-03-05 |
jamesxiong |
36 |
0 |
edit |
|
| anemia |
2.12 Dr. Gundrum |
Unfinished |
2023-03-14 |
jamesxiong |
19 |
0 |
edit |
|
| Blood/Marrow |
2.12 Dr. Gundrum |
Unfinished |
2023-03-12 |
jamesxiong |
10 |
0 |
edit |
|
| BREAST CANCER |
2.12 Dr. Gundrum DAY2 |
Unfinished |
2023-03-13 |
jamesxiong |
6 |
0 |
edit |
|
| Colon Cancer |
2.12 Dr. Gundrum |
Unfinished |
2023-03-11 |
jamesxiong |
28 |
0 |
edit |
|
| PANCREATIC CANCER |
2.12 Dr. Gundrum |
Unfinished |
2023-03-11 |
jamesxiong |
18 |
0 |
edit |
|
| Oncology Intro REMAK |
2.12 Dr. Gundrum |
Unfinished |
2023-03-14 |
jamesxiong |
124 |
0 |
edit |
|
| CINV |
2.12 Dr. Gundrum DAY 1 |
Unfinished |
2023-03-13 |
jamesxiong |
24 |
0 |
edit |
|
| Leukemia |
2.12 Dr. Gundrum |
Unfinished |
2023-03-13 |
jamesxiong |
16 |
0 |
edit |
|
| Pediatric/HSCT |
2.12 |
Unfinished |
2023-03-16 |
jamesxiong |
15 |
0 |
edit |
|
| Alzheimer Disease |
2.13 Decerbo |
Unfinished |
2023-03-30 |
jamesxiong |
21 |
0 |
edit |
|
| Stroke |
2.13 Decerbo |
Unfinished |
2023-03-29 |
jamesxiong |
14 |
0 |
edit |
|
| Headaches |
2.13 Lacy |
Unfinished |
2023-03-30 |
jamesxiong |
18 |
0 |
edit |
|
| MS |
2.13 Decerbo |
Unfinished |
2023-04-06 |
jamesxiong |
42 |
0 |
edit |
|
| Seizure |
2.13 Decerbo |
Unfinished |
2023-04-03 |
jamesxiong |
11 |
0 |
edit |
|
| Pain Day 1 |
2.13 Dr. Okolo |
Unfinished |
2023-04-06 |
jamesxiong |
51 |
0 |
edit |
|
| Pain Day 2 |
2.13 Dr. Okolo |
Unfinished |
2023-04-06 |
jamesxiong |
46 |
0 |
edit |
|
| Parkinson Disease |
2.13 Lacy |
Unfinished |
2023-04-06 |
jamesxiong |
8 |
0 |
edit |
|
| COPD |
2.14 |
Unfinished |
2023-04-22 |
jamesxiong |
54 |
0 |
edit |
|
| Cystic Fibrosis |
2.14 |
Unfinished |
2023-04-17 |
jamesxiong |
39 |
0 |
edit |
|
| Asthma |
2.14 |
Unfinished |
2023-04-23 |
jamesxiong |
22 |
0 |
edit |
|
| Asthma/Rhinitis |
Dr. Whittaker Drugs |
Unfinished |
2023-04-14 |
jamesxiong |
32 |
0 |
edit |
|
| Pulmonary HT |
Dr. Nguygen 2.14 |
Unfinished |
2023-04-20 |
jamesxiong |
29 |
0 |
edit |
|
| RSI AND NeuroBlock |
2.14 PUTNEY |
Unfinished |
2023-04-18 |
jamesxiong |
36 |
0 |
edit |
|
| PADIS |
2.14 PUTNEY |
Unfinished |
2023-04-18 |
jamesxiong |
35 |
0 |
edit |
|
| Hyperglycemia |
2.14 PUTNEY |
Unfinished |
2023-04-19 |
jamesxiong |
16 |
0 |
edit |
|
| Tobacco Use Disorder |
2.14 Nguyen |
Unfinished |
2023-04-20 |
jamesxiong |
23 |
0 |
edit |
|
| Brain Injury |
2.14 Dr. Putney |
Unfinished |
2023-04-20 |
jamesxiong |
29 |
0 |
edit |
|
| Introduction-Psych |
2.15 Okolo |
Unfinished |
2023-05-03 |
jamesxiong |
38 |
0 |
edit |
|
| Depression |
2.15 Dr. Kamyar |
Unfinished |
2023-05-04 |
jamesxiong |
27 |
0 |
edit |
|
| Schizo/Psychoses |
2.15 Okolo |
Unfinished |
2023-04-28 |
jamesxiong |
50 |
0 |
edit |
|
| SUD |
2.15 Dr. Okiolo |
Unfinished |
2023-04-29 |
jamesxiong |
41 |
0 |
edit |
|
| ADHD |
2.15 Okolo |
Unfinished |
2023-05-03 |
jamesxiong |
12 |
0 |
edit |
|
| Bipolar |
2.15 Dr. Kamyar |
Unfinished |
2023-05-04 |
jamesxiong |
6 |
0 |
edit |
|
